Gene · 406980
Papers3,730
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,730
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances in exosomal non-coding RNA-based therapeutic approaches for photoaging. | Skin Res Technol | 2023 | 37753673 | PubTator, text mining | PubMed |
| Blood miRNA levels associated with ADHD traits in children across six European birth cohorts. | BMC Psychiatry | 2023 | 37749515 | PubTator, text mining | PubMed |
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. | Cell Death Dis | 2023 | 37749143 | PubTator, text mining | PubMed |
| Identification and verification of a prognostic signature based on a miRNA-mRNA interaction pattern in colon adenocarcinoma. | Front Cell Dev Biol | 2023 | 37745305 | PubTator, text mining | PubMed |
| Extracellular microRNAs in Relation to Weight Loss-A Systematic Review and Meta-Analysis. | Noncoding RNA | 2023 | 37736899 | PubTator, text mining | PubMed |
| Oral squamous cell carcinomas: state of the field and emerging directions. | Int J Oral Sci | 2023 | 37736748 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. | Clin Transl Med | 2023 | 37735815 | PubTator, text mining | PubMed |
The long non-coding RNA BBOX1 antisense RNA 1 is upregulated in polycystic ovary syndrome (PCOS) and suppresses the role of microRNA-19b in the proliferation of ovarian granulose cells : Short title: BBOX1 antisense RNA 1 in cell proliferation. | BMC Womens Health | 2023 | 37735639 | PubTator, text mining | PubMed |
| The role of microRNAs in neurobiology and pathophysiology of the hippocampus. | Front Mol Neurosci | 2023 | 37727513 | PubTator, text mining | PubMed |
| microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration. | Front Bioeng Biotechnol | 2023 | 37720323 | PubTator, text mining | PubMed |
| Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis. | Front Cell Dev Biol | 2023 | 37719883 | PubTator, text mining | PubMed |
| Editorial: Host response to veterinary infectious diseases: role of coding and non-coding RNAs as biomarkers and disease modulators. | Front Vet Sci | 2023 | 37711434 | PubTator, text mining | PubMed |
| Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. | JCI Insight | 2023 | 37707956 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. | World J Gastroenterol | 2023 | 37701135 | PubTator, text mining | PubMed |
| Research progress on the role of extracellular vesicles in neurodegenerative diseases. | Transl Neurodegener | 2023 | 37697342 | PubTator, text mining | PubMed |
| Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis. | Cardiovasc Diabetol | 2023 | 37697288 | PubTator, text mining | PubMed |
| The functions and clinical application potential of exosomes derived from mesenchymal stem cells on wound repair: a review of recent research advances. | Front Immunol | 2023 | 37691943 | PubTator, text mining | PubMed |
| Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers? | Cancers (Basel) | 2023 | 37686652 | PubTator, text mining | PubMed |
| Can Genetic Markers Predict the Sporadic Form of Alzheimer's Disease? An Updated Review on Genetic Peripheral Markers. | Int J Mol Sci | 2023 | 37686283 | PubTator, text mining | PubMed |
| miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. | Int J Mol Sci | 2023 | 37686073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406980/papers?page=11